IL141666A0 - Hypoxia regulated genes - Google Patents

Hypoxia regulated genes

Info

Publication number
IL141666A0
IL141666A0 IL14166699A IL14166699A IL141666A0 IL 141666 A0 IL141666 A0 IL 141666A0 IL 14166699 A IL14166699 A IL 14166699A IL 14166699 A IL14166699 A IL 14166699A IL 141666 A0 IL141666 A0 IL 141666A0
Authority
IL
Israel
Prior art keywords
regulated genes
hypoxia regulated
hypoxia
genes
regulated
Prior art date
Application number
IL14166699A
Original Assignee
Quark Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quark Biotech Inc filed Critical Quark Biotech Inc
Publication of IL141666A0 publication Critical patent/IL141666A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL14166699A 1998-08-27 1999-08-27 Hypoxia regulated genes IL141666A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9815898P 1998-08-27 1998-08-27
US13268499P 1999-05-05 1999-05-05
PCT/US1999/020393 WO2000012139A1 (en) 1998-08-27 1999-08-27 Hypoxia regulated genes

Publications (1)

Publication Number Publication Date
IL141666A0 true IL141666A0 (en) 2002-03-10

Family

ID=26794273

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14166099A IL141660A0 (en) 1998-08-27 1999-08-27 Sequences characteristic of hypoxia-regulated gene transcription
IL14166699A IL141666A0 (en) 1998-08-27 1999-08-27 Hypoxia regulated genes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL14166099A IL141660A0 (en) 1998-08-27 1999-08-27 Sequences characteristic of hypoxia-regulated gene transcription

Country Status (6)

Country Link
EP (2) EP1115733A4 (en)
JP (2) JP2002525081A (en)
AU (1) AU5810999A (en)
CA (2) CA2341518A1 (en)
IL (2) IL141660A0 (en)
WO (2) WO2000012139A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4175662B2 (en) 1996-01-08 2008-11-05 インパルス ダイナミクス エヌ．ヴイ． Electric muscle control device
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
EP1002862A1 (en) * 1998-11-12 2000-05-24 Nitsch, Roger M., Prof. Dr. Methods of diagnosing or treating neurological diseases
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
WO2006073671A1 (en) 2004-12-09 2006-07-13 Impulse Dynamics Nv Protein activity modification
EP2295606A1 (en) * 2000-11-28 2011-03-16 Wyeth LLC Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
EP1398378A4 (en) * 2001-05-31 2005-03-30 Chiba Prefecture Nucleic acids isolated in neuroblastoma
EP1410013A4 (en) 2001-06-21 2006-02-01 Millennium Pharm Inc Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
JP2006515747A (en) * 2002-11-01 2006-06-08 ジェネンテック・インコーポレーテッド Compositions and methods for the treatment of immune related diseases
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
EP1670425A4 (en) * 2003-10-07 2008-04-16 Quark Pharmaceuticals Inc Bone morphogenetic protein (bmp) 2a and uses thereof
US8548583B2 (en) 2004-03-10 2013-10-01 Impulse Dynamics Nv Protein activity modification
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
WO2011092710A2 (en) 2010-02-01 2011-08-04 Metacure Limited Gastrointestinal electrical therapy
JP2011206049A (en) * 2010-03-08 2011-10-20 Sumio Sugano Necrosis marker and use thereof
JP2013220090A (en) * 2012-04-19 2013-10-28 Tohoku Univ Drug screening method for use in eye disease treatment
EP4035659A1 (en) 2016-11-29 2022-08-03 PureTech LYT, Inc. Exosomes for delivery of therapeutic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000353A1 (en) 1991-06-20 1993-01-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Sequences characteristic of human gene transcription product
US5731294A (en) * 1993-07-27 1998-03-24 Hybridon, Inc. Inhibition of neovasularization using VEGF-specific oligonucleotides
US5882914A (en) * 1995-06-06 1999-03-16 The Johns Hopkins University School Of Medicine Nucleic acids encoding the hypoxia inducible factor-1
WO1998039448A2 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
EP1002862A1 (en) * 1998-11-12 2000-05-24 Nitsch, Roger M., Prof. Dr. Methods of diagnosing or treating neurological diseases

Also Published As

Publication number Publication date
WO2000012139A1 (en) 2000-03-09
CA2341518A1 (en) 2000-03-09
WO2000012139B1 (en) 2000-05-04
IL141660A0 (en) 2002-03-10
WO2000012525A1 (en) 2000-03-09
EP1115733A1 (en) 2001-07-18
EP1115733A4 (en) 2003-01-22
CA2341705A1 (en) 2000-03-09
EP1107797A2 (en) 2001-06-20
JP2002525081A (en) 2002-08-13
EP1107797A4 (en) 2002-10-16
AU5810999A (en) 2000-03-21
JP2002523072A (en) 2002-07-30

Similar Documents

Publication Publication Date Title
ZA983487B (en) Leukemia associated genes
ZA989538B (en) Single mould-half alignment
TW509009U (en) Buckle
IL141666A0 (en) Hypoxia regulated genes
TW504971U (en) Buckle
EP1018307A4 (en) Buckle
AU133942S (en) Channel member
AU6417799A (en) Matrix-remodeling genes
EP1038957A4 (en) Tsa305 gene
GB9804376D0 (en) Clipboard
TW468395U (en) Buckle
GB2338890B (en) Improved backpack
TW432944U (en) Buckle
EP1092021A4 (en) Npy-y7 receptor gene
GB9824010D0 (en) Reins
GB9724828D0 (en) Gene
TW441255U (en) Buckle
GB9825899D0 (en) Stationery
GB9813027D0 (en) GSH-I & GSH-11 Genes
GB2306135B (en) Stationery sets
CA80420S (en) Planter
HU9700170V0 (en) Multi purpose shoe-last
GB9819721D0 (en) Novel gene
GB9817566D0 (en) Gene
GB9818734D0 (en) Gene